<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Uncomplicated Genital Chlamydia — One‑Page Reference Algorithm</title>
  <style>
    :root{
      --bg: #0b1020;
      --panel: #121733;
      --card: #161c3b;
      --muted: #a7b0d6;
      --text: #e9ecff;
      --accent: #6ea8fe;
      --accent-2: #22d3ee;
      --ok: #22c55e;
      --warn: #f59e0b;
      --danger: #ef4444;
      --shadow: 0 10px 30px rgba(2,8,23,.35);
    }
    @media (prefers-color-scheme: light){
      :root{ --bg:#f6f7fb; --panel:#ffffff; --card:#ffffff; --text:#101426; --muted:#5a6278; --shadow:0 10px 24px rgba(2,8,23,.08); }
    }
    *{box-sizing:border-box}
    html,body{height:100%}
    body{margin:0; font:16px/1.6 system-ui, -apple-system, Segoe UI, Roboto, Ubuntu, Cantarell, Noto Sans, "Helvetica Neue", Arial, "Apple Color Emoji","Segoe UI Emoji"; background: radial-gradient(1200px 700px at 90% -20%, rgba(34,211,238,.12), transparent 60%),var(--bg); color:var(--text)}
    .container{max-width:1100px; margin:0 auto; padding:clamp(16px,4vw,32px)}

    /* Header */
    .hdr{position:sticky; top:0; z-index:10; backdrop-filter:saturate(1.2) blur(8px); background:linear-gradient(180deg, rgba(15,23,42,.9), rgba(15,23,42,.6)); border-bottom:1px solid rgba(255,255,255,.06)}
    @media (prefers-color-scheme: light){ .hdr{ background:rgba(255,255,255,.8) } }
    .hdr-inner{display:flex; gap:18px; align-items:center; justify-content:space-between; padding:12px clamp(12px,3vw,22px)}
    .title{display:flex; align-items:center; gap:12px}
    .title h1{margin:0; font-size:clamp(18px,2.6vw,26px); letter-spacing:.2px}
    .pill{display:inline-flex; align-items:center; gap:8px; padding:6px 10px; border-radius:999px; background:linear-gradient(135deg, rgba(110,168,254,.25), rgba(34,211,238,.25)); color:var(--text); font-weight:600; box-shadow:var(--shadow)}
    .pill svg{width:16px; height:16px}
    .tools{display:flex; gap:10px}
    .btn{appearance:none; border:1px solid rgba(255,255,255,.12); color:var(--text); background:linear-gradient(180deg, rgba(255,255,255,.06), rgba(255,255,255,.03)); padding:8px 12px; border-radius:12px; font-weight:600; cursor:pointer}
    .btn:active{transform:translateY(1px)}

    /* Section nav */
    .nav{display:flex; gap:10px; flex-wrap:wrap; margin:18px 0 8px}
    .chip{display:inline-block; padding:8px 10px; border:1px solid rgba(255,255,255,.1); border-radius:999px; text-decoration:none; color:var(--text); font-weight:600; background:linear-gradient(180deg, rgba(255,255,255,.03), rgba(255,255,255,.02))}

    /* Cards */
    .grid{display:grid; grid-template-columns:repeat(12,1fr); gap:16px}
    .card{grid-column:span 12; background:linear-gradient(180deg, rgba(255,255,255,.06), rgba(255,255,255,.02)); border:1px solid rgba(255,255,255,.08); border-radius:18px; padding:18px 18px 16px; box-shadow:var(--shadow)}
    .card h2{font-size:clamp(16px,2.1vw,22px); margin:0 0 10px; letter-spacing:.2px}
    .kicker{color:var(--muted); font-weight:600; text-transform:uppercase; letter-spacing:.12em; font-size:12px; margin-bottom:4px}
    .lead{color:var(--muted)}
    .list{margin:10px 0 0; padding:0; list-style:none; display:grid; gap:10px}
    .li{display:grid; grid-template-columns:auto 1fr; gap:10px; align-items:flex-start}
    .li svg{flex:0 0 auto; width:18px; height:18px; margin-top:3px}

    .cols-6{grid-column:span 12}
    .cols-4{grid-column:span 12}
    .cols-3{grid-column:span 12}
    @media(min-width:760px){ .cols-6{grid-column:span 6} .cols-4{grid-column:span 4} .cols-3{grid-column:span 3} }

    /* Table */
    table{width:100%; border-collapse:separate; border-spacing:0; overflow:hidden; border-radius:14px; border:1px solid rgba(255,255,255,.08)}
    th, td{padding:12px 14px; text-align:left; vertical-align:top}
    thead th{background:linear-gradient(180deg, rgba(255,255,255,.12), rgba(255,255,255,.06)); font-size:14px}
    tbody tr + tr td{border-top:1px dashed rgba(255,255,255,.12)}
    .tag{display:inline-flex; align-items:center; gap:6px; padding:4px 8px; border-radius:999px; border:1px solid rgba(255,255,255,.12); font-size:12px; font-weight:700}
    .tag.ok{border-color:rgba(34,197,94,.5)}
    .tag.warn{border-color:rgba(245,158,11,.5)}
    .tag.danger{border-color:rgba(239,68,68,.5)}

    /* Details */
    details{border:1px solid rgba(255,255,255,.1); border-radius:12px; background:linear-gradient(180deg, rgba(255,255,255,.06), rgba(255,255,255,.03));}
    details + details{margin-top:10px}
    summary{cursor:pointer; padding:10px 14px; font-weight:700; list-style:none}
    summary::-webkit-details-marker{display:none}
    details > div{padding: 0 14px 14px}

    /* Footer */
    footer{margin:24px 0 8px; color:var(--muted); font-size:13px}

    /* Print */
    @media print{
      .hdr, .tools, .nav{display:none}
      body{background:#fff; color:#000}
      .card{box-shadow:none; border:1px solid #ddd}
      .container{padding:12mm}
      table{border-color:#ccc}
    }
  </style>
</head>
<body>
  <header class="hdr">
    <div class="hdr-inner container">
      <div class="title">
        <span class="pill" title="Clinical quick reference">
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M20 21V7a2 2 0 0 0-2-2h-6a2 2 0 0 0-2 2v14"/><path d="M16 21V5a2 2 0 0 0-2-2H6a2 2 0 0 0-2 2v16"/></svg>
          Quick Ref
        </span>
        <h1>Uncomplicated Genital Chlamydia — One‑Page Algorithm</h1>
      </div>
      <div class="tools">
        <button class="btn" onclick="window.print()">Print</button>
      </div>
    </div>
  </header>

  <main class="container">
    <nav class="nav" aria-label="Section links">
      <a class="chip" href="#who">Who to Test</a>
      <a class="chip" href="#suspect">When to Suspect</a>
      <a class="chip" href="#testing">How to Test</a>
      <a class="chip" href="#tx">Treatment</a>
      <a class="chip" href="#special">Special Groups</a>
      <a class="chip" href="#partners">Partner Mgmt</a>
      <a class="chip" href="#follow">Follow‑up</a>
      <a class="chip" href="#safety">Safety & Interactions</a>
      <a class="chip" href="#ddx">Differential Dx</a>
    </nav>

    <section class="grid" id="top">
      <!-- WHO TO TEST -->
      <article class="card cols-6" id="who">
        <div class="kicker">Screening / Case‑finding</div>
        <h2>Who to Test</h2>
        <p class="lead">Use NAAT screening proactively in higher‑risk people and with any compatible symptoms.</p>
        <ul class="list">
          <li class="li">
            <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg>
            <span><strong>All sexually active women &lt;25 y</strong> annually; consider more often with a new partner.</span>
          </li>
          <li class="li">
            <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg>
            <span><strong>Sexual partners</strong> of people with confirmed/suspected chlamydia.</span>
          </li>
          <li class="li">
            <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg>
            <span>Anyone worried about a recent exposure — <em>test now</em>; if exposure was within 2 weeks and negative, <em>repeat at 2 weeks</em>.</span>
          </li>
          <li class="li">
            <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg>
            <span>People &lt;25 y treated for chlamydia in the last 3 months; people with ≥2 partners in the past 12 months.</span>
          </li>
          <li class="li">
            <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg>
            <span>All women seeking <abbr title="Termination of pregnancy">TOP</abbr>; all attendees at GUM clinics.</span>
          </li>
        </ul>
      </article>

      <!-- WHEN TO SUSPECT -->
      <article class="card cols-6" id="suspect">
        <div class="kicker">Clinical features</div>
        <h2>When to Suspect</h2>
        <details open>
          <summary>Women</summary>
          <div>
            <ul class="list">
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Increased or purulent vaginal discharge; mucopurulent cervicitis; friable cervix.</span></li>
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Post‑coital / inter‑menstrual bleeding; deep dyspareunia.</span></li>
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Dysuria, pelvic pain/tenderness, cervical motion tenderness.</span></li>
            </ul>
          </div>
        </details>
        <details>
          <summary>Men</summary>
          <div>
            <ul class="list">
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Dysuria; mucoid/mucopurulent urethral discharge; urethral discomfort/urethritis.</span></li>
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Epididymo‑orchitis; reactive arthritis.</span></li>
            </ul>
          </div>
        </details>
        <details>
          <summary>Other sites / syndromes</summary>
          <div>
            <ul class="list">
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Rectal: anal discharge, proctitis, anorectal discomfort — often asymptomatic.</span></li>
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>LGV features: tenesmus, bloody discharge, anorectal pain; consider especially in MSM.</span></li>
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Conjunctivitis: typically unilateral low‑grade irritation (may be bilateral).</span></li>
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Oropharynx: pharyngitis/sore throat — usually asymptomatic.</span></li>
            </ul>
          </div>
        </details>
      </article>

      <!-- HOW TO TEST -->
      <article class="card cols-6" id="testing">
        <div class="kicker">Diagnostics</div>
        <h2>How to Test</h2>
        <p class="lead">Confirm with <strong>NAAT</strong>; choose the most sensitive specimen for the site.</p>
        <ul class="list">
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Women:</strong> Self‑taken <em>vulvovaginal swab</em> (preferred) or endocervical swab; FCU if preferred (hold urine ≥1 h; collect first ~20 mL).</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Men:</strong> First‑catch urine (preferred); urethral swab alternative (insert 2–4 cm, rotate once).</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Extra‑genital:</strong> Take <em>rectal swabs</em> for symptomatic people; test for LGV if proctitis, and in HIV‑positive MSM with CT detected at any site.</span></li>
        </ul>
      </article>

      <!-- TREATMENT -->
      <article class="card cols-6" id="tx">
        <div class="kicker">Antibiotic regimen</div>
        <h2>Treatment (Uncomplicated)</h2>
        <p class="lead">Encourage referral to <strong>GUM</strong>. If declined/unavailable, treat in primary care and address partners & STI screening.</p>
        <table aria-describedby="tx">
          <thead>
            <tr><th style="width:42%">Regimen</th><th>Adults & ≥13 y (non‑pregnant)</th><th>Notes</th></tr>
          </thead>
          <tbody>
            <tr>
              <td><strong>Doxycycline</strong></td>
              <td>100 mg PO <abbr title="twice daily">BID</abbr> × 7 days</td>
              <td><span class="tag danger">avoid in pregnancy & breastfeeding</span></td>
            </tr>
            <tr>
              <td><strong>Azithromycin</strong></td>
              <td>1 g PO once, then 500 mg PO daily × 2 days</td>
              <td>Use if doxycycline contraindicated/not tolerated</td>
            </tr>
            <tr>
              <td><strong>Erythromycin</strong></td>
              <td>500 mg PO <abbr title="twice daily">BID</abbr> × 10–14 days<br/>or 500 mg PO <abbr title="four times daily">QID</abbr> × 7 days</td>
              <td>Consider if doxy/azithro unsuitable</td>
            </tr>
            <tr>
              <td><strong>Ofloxacin</strong></td>
              <td>200 mg PO BID × 7 days<br/>or 400 mg PO daily × 7 days</td>
              <td><span class="tag warn">reserve</span> Contraindicated in pregnancy/children; MHRA restrictions on fluoroquinolones</td>
            </tr>
          </tbody>
        </table>
        <details style="margin-top:12px">
          <summary>Pregnancy — options</summary>
          <div>
            <ul class="list">
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Azithromycin:</strong> 1 g once, then 500 mg daily × 2 days.</span></li>
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Erythromycin:</strong> 500 mg QID × 7 days <em>or</em> 500 mg BID × 14 days.</span></li>
              <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Amoxicillin:</strong> 500 mg TID × 7 days.</span></li>
            </ul>
            <p class="lead" style="margin-top:8px"><strong>Avoid doxycycline.</strong> Discuss with midwife/obstetrician and/or GUM if uncertain.</p>
          </div>
        </details>
      </article>

      <!-- SPECIAL POPULATIONS -->
      <article class="card cols-6" id="special">
        <div class="kicker">Context</div>
        <h2>Special Groups & Referral</h2>
        <ul class="list">
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Safeguarding:</strong> If an STI is suspected/diagnosed in a child or young person, consult GUM/paediatrics early and follow local safeguarding policies.</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Urgent GUM referral</strong> for non‑response to 1st‑line therapy or if <strong>PID</strong> suspected.</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Offer written information on transmission, treatment, complications, and prevention.</span></li>
        </ul>
      </article>

      <!-- PARTNER MANAGEMENT -->
      <article class="card cols-6" id="partners">
        <div class="kicker">Prevention of reinfection</div>
        <h2>Partner Management</h2>
        <ul class="list">
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Treat current partner(s)</strong> empirically to reduce reinfection and onward transmission.</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Avoid sexual contact</strong> (including oral sex) until patient and partners have completed therapy (or <em>7 days after azithromycin</em>).</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Encourage <strong>GUM attendance</strong> for full STI screen (gonorrhoea, HIV, hepatitis B, syphilis) and partner notification support. With consent, share details to GUM solely for partner notification if attendance is not possible.</span></li>
        </ul>
      </article>

      <!-- FOLLOW UP -->
      <article class="card cols-6" id="follow">
        <div class="kicker">Aftercare</div>
        <h2>Follow‑up</h2>
        <ul class="list">
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>Check adherence and symptom resolution; reinforce condoms/regular testing.</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Test of cure (TOC)</strong> is <em>not routine</em>. Indicated in pregnancy, poor adherence, or persistent symptoms.</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span>When needed, <strong>defer TOC ≥3 weeks</strong> after treatment to avoid false positive NAAT.</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Re‑test</strong> all people <strong>&lt;25 y</strong> at <strong>3–6 months</strong> (reinfection check). Consider in &gt;25 y if high risk.</span></li>
        </ul>
      </article>

      <!-- SAFETY -->
      <article class="card cols-6" id="safety">
        <div class="kicker">Key prescribing checks</div>
        <h2>Safety & Interactions — Quick Cues</h2>
        <ul class="list">
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Pregnancy/Breastfeeding:</strong> Avoid tetracyclines (doxycycline).</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>QT prolongation:</strong> Macrolides (azithro/erythro) — check cardiac history, electrolytes, and QT‑prolonging meds.</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Fluoroquinolones:</strong> Reserve ofloxacin for when other recommended antibiotics are inappropriate; contraindicated in pregnancy/children; counsel on rare but serious adverse effects.</span></li>
          <li class="li"><svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M20 6L9 17l-5-5"/></svg><span><strong>Common interactions:</strong> Warfarin (monitor INR), digoxin/statins (macrolides), antacids/iron/zinc (separate from doxycycline by 2–3 h), retinoids (avoid with tetracyclines).</span></li>
        </ul>
      </article>

      <!-- DIFFERENTIALS -->
      <article class="card cols-6" id="ddx">
        <div class="kicker">Think broader</div>
        <h2>Differential Diagnosis</h2>
        <div class="lead">Gonorrhoea, BV, candidiasis, trichomoniasis, PID, UTI.</div>
      </article>
    </section>

    <footer>
      <div>For NHS healthcare professionals. Based on your uploaded guidance on <em>uncomplicated genital chlamydia</em> (last revised Feb 2025). Adapt to local microbiology and formulary.</div>
    </footer>
  </main>
</body>
</html>